REVB

REVB

Revelation Biosciences Inc

Rev โ€”top 1%5Y
Hold

Revelation Biosciences is a clinical-stage biopharmaceutical company developing therapies to rebalance inflammation for health optimization. Its lead products include Gemini for inflammation modulation and GEM-AKI and GEM-CKD for kidney injury and disease.

โš•๏ธ Healthcare NASDAQ Listed 2020 $ USD
$1,000 invested 5 years ago โ†’$0today

Score Overview

1 Year
Scoreโ€”
Net Growth-20.61%
Net TrendShrank
Net Income Consistencyโ€”
Rev Growthโ€”
Rev TrendShrank
Revenue Consistencyโ€”
5 Years
Scoreโ€”
Net Growth10.31%
Net Trend60%
Net Income Consistencyโ€”
Rev Growthโ€”
Rev TrendNever
Revenue Consistencyโ€”
All Time
Scoreโ€”
Net Growth-76x
Net Trend50%
Net Income Consistency
Rev Growthโ€”
Rev TrendNever
Revenue Consistency

See the full market ranking โ†’

Revelation Biosciences Inc fundamental performance

Across Revelation Biosciences Inc's full reported history, from 2020 to 2025, net income went from -$ 136.41K to -$ 8M. Revenue increased in 0% of the years measured; net income in 50%.

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-08-12
$ 1.11โ€”
1 Year2025-08-12
$ 9.68-88.53%
5 Years2021-08-12
$ 1000K-100.00%
All Time2020-11-17
$ 1000K-100.00%

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Year
2026$ 0.00-$ 10M$ 11M
2025$ 0.00-$ 8M$ 10M
2024$ 0.00-$ 15M$ 6M
2023$ 0.00-$ 120.25K$ 11M
2022$ 0.00-$ 10M$ 5M
2021$ 0.00-$ 11M$ 1M
IPO2020-$ 136.41K$ 4M

Explore beyond REVB

You're looking at Revelation Biosciences Inc. Members apply the same fundamental framework across all 3,860 companies we cover.

$99/year $149 founding price

Unlock Holder Dashboard

30-day money-back guarantee.

Explore other companies